66 related articles for article (PubMed ID: 21254589)
1. [Effects of subchronic hemantane administration on dopamine and serotonin receptors in intact and MPP+-treated rat brain ex vivo].
Zimin IA; Kapitsa IG; Voronina TA; Kovalev GI
Eksp Klin Farmakol; 2010 Nov; 73(11):2-5. PubMed ID: 21254589
[TBL] [Abstract][Full Text] [Related]
2. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
Abaimov DA; Zimin IA; Kovalev GI
Eksp Klin Farmakol; 2008; 71(1):18-21. PubMed ID: 18365481
[TBL] [Abstract][Full Text] [Related]
3. [A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
Zimin IA; Logvinov IO; Antipova TA; Kovalev GI
Eksp Klin Farmakol; 2011; 74(1):11-4. PubMed ID: 21476268
[TBL] [Abstract][Full Text] [Related]
4. Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy.
Sánchez MG; Estrada-Camarena E; Bélanger N; Morissette M; Di Paolo T
Neuropharmacology; 2011 Mar; 60(4):642-52. PubMed ID: 21144854
[TBL] [Abstract][Full Text] [Related]
5. [The acute and subchronic effects of hemantane on [3H]-dopamine reuptake in rat striatal synaptosomes ex vivo].
Abaimov DA; Kovalev GI
Eksp Klin Farmakol; 2007; 70(4):11-4. PubMed ID: 18078034
[TBL] [Abstract][Full Text] [Related]
6. [Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity].
Val'dman EA; Nerobkova LN; Voronina TA
Eksp Klin Farmakol; 2004; 67(1):7-10. PubMed ID: 15079899
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
[TBL] [Abstract][Full Text] [Related]
8. [Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
Nepoklonov AV; Kapitsa IG; Ivanova EA; Voronina TA; Val'dman EA
Eksp Klin Farmakol; 2012; 75(11):3-6. PubMed ID: 23323324
[TBL] [Abstract][Full Text] [Related]
9. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
10. [Influence of hemantane and doxycycline on MPTP-evoked behavior violations in C57BL/6 mice].
Kovalev GI; Salimov RM
Eksp Klin Farmakol; 2011; 74(5):3-5. PubMed ID: 21809690
[TBL] [Abstract][Full Text] [Related]
11. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
Frohna PA; Rothblat DS; Joyce JN; Schneider JS
Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
[TBL] [Abstract][Full Text] [Related]
12. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
14. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
15. [Effect of hemantane on bioelectric activity of brain in mice with MPTP-induced Parkinson syndrome].
Kapitsa IG; Kokshenev II; Nerobkova LN; Val'dman EA; Voronina TA
Eksp Klin Farmakol; 2013; 76(4):3-6. PubMed ID: 23762980
[TBL] [Abstract][Full Text] [Related]
16. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
17. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
[TBL] [Abstract][Full Text] [Related]
18. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
[TBL] [Abstract][Full Text] [Related]
19. Prenatal stress in the rat alters 5-HT1A receptor binding in the ventral hippocampus.
Van den Hove DL; Lauder JM; Scheepens A; Prickaerts J; Blanco CE; Steinbusch HW
Brain Res; 2006 May; 1090(1):29-34. PubMed ID: 16677618
[TBL] [Abstract][Full Text] [Related]
20. Effect of continuous exposure to alternating magnetic field (50 Hz, 0.5 mT) on serotonin and dopamine receptors activity in rat brain.
Janać B; Tovilović G; Tomić M; Prolić Z; Radenović L
Gen Physiol Biophys; 2009; 28 Spec No():41-6. PubMed ID: 19893078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
